Who Paid My Doc
Accurian
Device Neuro Pain (includes Interventional)
PDI 00763000140809
General payments
$268,633
Research payments
$202,062
Through program year 2025, $268,633 in general payments and $202,062 in research payments were reported against Accurian (Neuro Pain (includes Interventional)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $35,163 | 580 |
| 2025 | Research | $51,760 | 21 |
| 2024 | General | $37,589 | 1,101 |
| 2024 | Research | $50,909 | 17 |
| 2023 | General | $57,955 | 1,617 |
| 2023 | Research | $56,859 | 16 |
| 2022 | General | $102,550 | 1,257 |
| 2022 | Research | $42,535 | 6 |
| 2021 | General | $35,375 | 788 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 29 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,343 general · 60 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.